However, the specific mechanism by which SRPK1 regulates glioma cell proliferation remains unclear, and there is still an urgent need to continue exploring SRPK1-related signaling pathways in gliomas to find new therapeutic approaches. This evidence concerns the gene SRPK1 and central nervous system cancer.